These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25720066)

  • 1. The effect of altered sphingolipid acyl chain length on various disease models.
    Park WJ; Park JW
    Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
    Park JW; Park WJ; Futerman AH
    Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease.
    Richardson WJ; Humphrey SB; Sears SM; Hoffman NA; Orwick AJ; Doll MA; Doll CL; Xia C; Hernandez-Corbacho M; Snider JM; Obeid LM; Hannun YA; Snider AJ; Siskind LJ
    Mol Pharmacol; 2024 Feb; 105(3):131-143. PubMed ID: 38164625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of sphingolipid metabolism: from synthesis to breakdown.
    Gault CR; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sphingolipid salvage pathway in ceramide metabolism and signaling.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
    Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
    J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eleven residues determine the acyl chain specificity of ceramide synthases.
    Tidhar R; Zelnik ID; Volpert G; Ben-Dor S; Kelly S; Merrill AH; Futerman AH
    J Biol Chem; 2018 Jun; 293(25):9912-9921. PubMed ID: 29632068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide synthases at the centre of sphingolipid metabolism and biology.
    Mullen TD; Hannun YA; Obeid LM
    Biochem J; 2012 Feb; 441(3):789-802. PubMed ID: 22248339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides.
    Kihara A
    Prog Lipid Res; 2016 Jul; 63():50-69. PubMed ID: 27107674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide metabolism in mouse tissue.
    Schiffmann S; Birod K; Männich J; Eberle M; Wegner MS; Wanger R; Hartmann D; Ferreiros N; Geisslinger G; Grösch S
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1886-94. PubMed ID: 23792024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes.
    Park JW; Park WJ; Kuperman Y; Boura-Halfon S; Pewzner-Jung Y; Futerman AH
    Hepatology; 2013 Feb; 57(2):525-32. PubMed ID: 22911490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea.
    Brüggen B; Kremser C; Bickert A; Ebel P; Vom Dorp K; Schultz K; Dörmann P; Willecke K; Dedek K
    Eur J Neurosci; 2016 Jul; 44(1):1700-13. PubMed ID: 27086873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide synthases: Reflections on the impact of Dr. Lina M. Obeid.
    Kim JL; Mestre B; Shin SH; Futerman AH
    Cell Signal; 2021 Jun; 82():109958. PubMed ID: 33607256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipids' role in radiotherapy for prostate cancer.
    Hajj C; Haimovitz-Friedman A
    Handb Exp Pharmacol; 2013; (216):115-30. PubMed ID: 23563654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism.
    Mullen TD; Spassieva S; Jenkins RW; Kitatani K; Bielawski J; Hannun YA; Obeid LM
    J Lipid Res; 2011 Jan; 52(1):68-77. PubMed ID: 20940143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
    Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.
    Pewzner-Jung Y; Park H; Laviad EL; Silva LC; Lahiri S; Stiban J; Erez-Roman R; Brügger B; Sachsenheimer T; Wieland F; Prieto M; Merrill AH; Futerman AH
    J Biol Chem; 2010 Apr; 285(14):10902-10. PubMed ID: 20110363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.